• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重型β地中海贫血患者的动脉僵硬度和内皮功能

Arterial stiffness and endothelial function in patients with beta-thalassemia major.

作者信息

Cheung Y F, Chan Godfrey C F, Ha S Y

机构信息

Division of Paediatric Cardiology, Grantham Hospital, The University of Hong Kong, China.

出版信息

Circulation. 2002 Nov 12;106(20):2561-6. doi: 10.1161/01.cir.0000037225.92759.a7.

DOI:10.1161/01.cir.0000037225.92759.a7
PMID:12427652
Abstract

BACKGROUND

Increased iron store has been linked to risk of cardiovascular disease. Structural alterations of arteries in beta-thalassemia major patients and in vitro functional disturbance of vascular endothelial cells by thalassemic serum have been described. We sought to determine whether arterial stiffness and endothelial function are altered in vivo.

METHODS AND RESULTS

Thirty thalassemia patients (16 male) aged 22.2+/-7.4 years were recruited. Left ventricular (LV) mass and function were assessed echocardiographically. Carotid and brachioradial artery stiffness was assessed by stiffness index and pulse-wave velocity (PWV), respectively. Brachial artery endothelial function was assessed by vascular response to reactive hyperemia (flow-mediated dilation [FMD]) and sublingual glyceryl trinitrate. These indexes were compared with those of 30 age- and sex-matched controls. None of the patients had LV systolic or diastolic dysfunction. When compared with controls, patients had greater absolute (113.8+/-38.0 versus 109.0+/- 32.6 g, P=0.04) and indexed (82.4+/-17.5 versus 66.7+/-12.7 g/m(2), P<0.001) LV mass, carotid artery stiffness index (8.1+/-3.5 versus 5.5+/-1.6, P<0.001), and brachioradial PWV (8.9+/-2.4 versus 7.9+/-1.7 m/s, P= 0.03). Their FMD was impaired (3.5+/-3.3% versus 8.8+/-3.9%, P<0.001), whereas glyceryl trinitrate- mediated dilation was preserved (17.9+/-7.6% versus 16.3+/-6.1%, P=0.40). Both stiffness index and PWV correlated inversely with magnitude of FMD (r=-0.40, P=0.03; r=-0.41, P=0.03) and positively with indexed LV mass (r=0.50, P=0.005; r=0.40, P=0.027). Nonetheless, no significant correlation existed between ferritin level and carotid stiffness, PWV, or FMD.

CONCLUSIONS

Increased arterial stiffness, endothelial dysfunction, and LV hypertrophy occur in patients with beta-thalassemia major, which may result in reduction of mechanical efficiency of the heart.

摘要

背景

铁储存增加与心血管疾病风险相关。已有研究描述了重型β地中海贫血患者动脉结构改变以及地中海贫血血清对血管内皮细胞的体外功能干扰。我们试图确定体内动脉僵硬度和内皮功能是否发生改变。

方法与结果

招募了30例年龄为22.2±7.4岁的地中海贫血患者(16例男性)。通过超声心动图评估左心室(LV)质量和功能。分别通过僵硬度指数和脉搏波速度(PWV)评估颈动脉和肱桡动脉僵硬度。通过对反应性充血的血管反应(血流介导的扩张[FMD])和舌下硝酸甘油评估肱动脉内皮功能。将这些指标与30例年龄和性别匹配的对照组进行比较。所有患者均无左心室收缩或舒张功能障碍。与对照组相比,患者的左心室绝对质量(113.8±38.0对109.0±32.6 g,P = 0.04)和指数化质量(82.4±17.5对66.7±12.7 g/m²,P < 0.001)更大,颈动脉僵硬度指数(8.1±3.5对5.5±1.6,P < 0.001)和肱桡动脉PWV(8.9±2.4对7.9±1.7 m/s,P = 0.03)更高。他们的FMD受损(3.5±3.3%对8.8±3.9%,P < 0.001),而硝酸甘油介导的扩张保留(17.9±7.6%对16.3±6.1%,P = 0.40)。僵硬度指数和PWV均与FMD幅度呈负相关(r = -0.40,P = 0.03;r = -0.41,P = 0.03),与指数化左心室质量呈正相关(r = 0.50,P = 0.005;r = 0.40,P = 0.027)。然而,铁蛋白水平与颈动脉僵硬度、PWV或FMD之间无显著相关性。

结论

重型β地中海贫血患者存在动脉僵硬度增加、内皮功能障碍和左心室肥厚,这可能导致心脏机械效率降低。

相似文献

1
Arterial stiffness and endothelial function in patients with beta-thalassemia major.重型β地中海贫血患者的动脉僵硬度和内皮功能
Circulation. 2002 Nov 12;106(20):2561-6. doi: 10.1161/01.cir.0000037225.92759.a7.
2
Endothelial function and arterial stiffness in sickle-thalassemia patients.
Atherosclerosis. 2007 Apr;191(2):427-32. doi: 10.1016/j.atherosclerosis.2006.04.015. Epub 2006 May 18.
3
Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major.地拉罗司(ICL670)对重型β地中海贫血患者动脉功能的影响。
Br J Haematol. 2008 May;141(5):728-33. doi: 10.1111/j.1365-2141.2008.07092.x. Epub 2008 Mar 3.
4
Oxidised low-density lipoprotein and arterial function in beta-thalassemia major.重型β地中海贫血患者中的氧化型低密度脂蛋白与动脉功能
Eur J Haematol. 2009 Jun;82(6):477-83. doi: 10.1111/j.1600-0609.2009.01236.x.
5
A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.系统性自身免疫性疾病患者动脉僵硬度、肱动脉血流介导的血管舒张功能及颈动脉内膜中层厚度的比较研究
Clin Rheumatol. 2009 Jun;28(6):655-62. doi: 10.1007/s10067-009-1118-y. Epub 2009 Feb 18.
6
Serial assessment of arterial structure and function in patients with coarctation of the aorta undergoing stenting.对接受支架置入术的主动脉缩窄患者的动脉结构和功能进行系列评估。
Int J Cardiovasc Imaging. 2016 May;32(5):729-39. doi: 10.1007/s10554-015-0827-3. Epub 2016 Jan 2.
7
Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure.血管僵硬度与内皮功能障碍:不同血压水平下的相关性
Blood Press. 2012 Feb;21(1):31-8. doi: 10.3109/08037051.2011.617045. Epub 2011 Oct 27.
8
Coronary Microvascular function, Peripheral Endothelial Function and Carotid IMT in beta-thalassemia minor.β-地中海贫血轻度患者的冠状动脉微血管功能、外周血管内皮功能和颈动脉 IMT
Thromb Res. 2013 Jun;131(6):e247-52. doi: 10.1016/j.thromres.2013.03.013. Epub 2013 May 15.
9
Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.糖尿病患者血压正常且血糖正常的一级亲属的内皮功能和动脉僵硬度与代谢综合征无关。
Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):349-56. doi: 10.1016/j.numecd.2007.03.008. Epub 2007 Nov 1.
10
Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling.射血分数保留的低流量重度主动脉瓣狭窄、N末端脑钠肽前体(NT-proBNP)与心血管重塑
J Heart Valve Dis. 2011 May;20(3):301-10.

引用本文的文献

1
Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.与重型地中海贫血患者相比,成人中间型地中海贫血定期输血患者组织铁沉积和心脏功能的磁共振评估
J Clin Med. 2024 Aug 14;13(16):4791. doi: 10.3390/jcm13164791.
2
Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives.探讨地中海贫血患者骨髓微环境:潜在的治疗新选择。
Front Immunol. 2024 Aug 5;15:1403458. doi: 10.3389/fimmu.2024.1403458. eCollection 2024.
3
Cardiac complications in thalassemia throughout the lifespan: Victories and challenges.
地中海贫血症患者一生中的心脏并发症:胜利与挑战。
Ann N Y Acad Sci. 2023 Dec;1530(1):64-73. doi: 10.1111/nyas.15078. Epub 2023 Oct 30.
4
Aortic elasticity changes in thalassemia due to heart and liver iron deposition.地中海贫血中由于心脏和肝脏铁沉积导致的主动脉弹性变化。
Caspian J Intern Med. 2023 Summer;14(3):460-469.
5
The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major.SIRT1/FOXO1信号通路在重型β地中海贫血患儿心血管风险早期检测中的价值
Biomedicines. 2022 Oct 17;10(10):2601. doi: 10.3390/biomedicines10102601.
6
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.2021年地中海贫血国际联合会输血依赖型地中海贫血管理指南
Hemasphere. 2022 Jul 29;6(8):e732. doi: 10.1097/HS9.0000000000000732. eCollection 2022 Aug.
7
Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.依赖输血的溶血性贫血患者中未结合血红蛋白、血红素和铁的血管毒性和促炎作用。
Br J Haematol. 2021 May;193(3):637-658. doi: 10.1111/bjh.17361. Epub 2021 Mar 15.
8
Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives ~.β 僵硬度参数在评估动脉粥样硬化方面有用吗?~ 其临床意义、局限性和未来展望~。
J Atheroscler Thromb. 2021 May 1;28(5):435-453. doi: 10.5551/jat.RV17047. Epub 2021 Feb 13.
9
Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.非转铁蛋白结合铁成为焦点:铁的血管毒性和动脉粥样硬化作用的新机制见解。
Antioxid Redox Signal. 2021 Aug 20;35(6):387-414. doi: 10.1089/ars.2020.8167. Epub 2021 Mar 22.
10
Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.溶血产物的毒性与内皮细胞:二次打击模型。
Toxins (Basel). 2019 Nov 13;11(11):660. doi: 10.3390/toxins11110660.